Ahmedabad, July 29, 2020: Ahmedabad-based Cadila Pharmaceuticals Limited recently announced the launch of biosimilar Rituximab for India market. Biosimilar Rituximab…
By Dr.SangitaSatyamurthy, Consultant – Rheumatology, Columbia Asia Hospital Whitefield Health is wealth, goes a wise old saying as nothing is…
Mumbai, November 11, 2018: Eli Lilly and Company (India) Pvt. Ltd. (“Lilly India”) announced the launch of Olumiant™ (baricitinib). This…
New Delhi, May 18, 2018: Patients in Cuba will have better access to therapy for lymphoma and rheumatoid arthritis The…
New Delhi, February 21, 2018: In January 2018, BIOCAD’s infliximab biosimilar was approved in Russia. The approval was based on…